Risk Factors for Fear of Recurrence in Head and Neck Cancer Patients.

Riggauer, Julia; Blaser, Daniela; Eliçin, Olgun; Gahl, Brigitta; Giger, Roland; Mueller, Simon Andreas (2022). Risk Factors for Fear of Recurrence in Head and Neck Cancer Patients. (In Press). The Laryngoscope Wiley 10.1002/lary.30340

[img]
Preview
Text
The_Laryngoscope_-_2022_-_Riggauer_-_Risk_Factors_for_Fear_of_Recurrence_in_Head_and_Neck_Cancer_Patients.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (297kB) | Preview

OBJECTIVE

Fear of recurrence (FoR) affects the quality of life of head and neck cancer survivors. Identification of factors predisposing to FoR may help to recognize and treat patients at risk.

MATERIALS AND METHODS

For this exploratory study, 101 disease-free head and neck cancer survivors completed a cross-sectional survey in 2017 that included the FoR questionnaire at a random point in time during their follow-up. Additionally, the patients were asked to choose their favorite among four follow-up schedules with or without systematic imaging and varying frequency of visits.

RESULTS

Elevated FoR was present in 36.6% of patients. Females and patients ≤65 years showed significantly higher FoR overall scores than males (score difference 3.40; CI 0.49-6.32; p = 0.022) and patients >65 years (score difference 4.25; CI 1.58-6.92; p = 0.002). A history of cancer recurrence or second primary malignancy increased the relative risk (RR) for elevated FoR (RR 1.7; CI 1.01-2.86; p = 0.046). Tumor stage and treatment modality were not significantly associated with elevated FoR or FoR overall score. Higher FoR overall scores were recorded in patients who favored intensive follow-up plans (mean overall FoR score 18 vs. 15; SD 7.7; p = 0.076) and systematic imaging in follow-up (17 vs. 13, SD 7.1; p = 0.034).

CONCLUSION

Fear of recurrence in head and neck cancer patients is associated with female sex, younger age, and history of a past recurrence or second primary malignancy. Due to its high prevalence, it should be addressed in clinical practice and future research.

LEVEL OF EVIDENCE

N/A Laryngoscope, 2022.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ear, Nose and Throat Disorders (ENT)
04 Faculty of Medicine > Pre-clinic Human Medicine > CTU Bern
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Blaser, Daniela; Eliçin, Olgun; Gahl, Brigitta; Giger, Roland and Müller, Simon Andreas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1531-4995

Publisher:

Wiley

Language:

English

Submitter:

Pubmed Import

Date Deposited:

05 Sep 2022 14:32

Last Modified:

09 Sep 2022 09:22

Publisher DOI:

10.1002/lary.30340

PubMed ID:

36054694

Uncontrolled Keywords:

cancer follow-up cancer recurrence cancer survivors fear of recurrence head and neck cancer

BORIS DOI:

10.48350/172639

URI:

https://boris.unibe.ch/id/eprint/172639

Actions (login required)

Edit item Edit item
Provide Feedback